Semaglutide vs Tirzepatide: A Nurse Practitioner's Guide

If you've been researching weight-loss medications, you've almost certainly run into the same two names over and over: semaglutide and tirzepatide. They're the leading GLP-1 medications, they're everywhere in the news, and patients across the Treasure Coast ask us about them almost every week. This guide walks through how each one actually works, what the research shows about results and side effects, what they cost, and how we decide between them inside a medically supervised program at Delphi.

The short answer: semaglutide vs tirzepatide at a glance

Both medications are once-weekly injections that help regulate appetite and blood sugar, and both can produce significant weight loss when paired with real lifestyle change. The core difference is how many hormone pathways they act on: semaglutide targets one gut hormone receptor, while tirzepatide targets two.

That single distinction drives most of the practical differences you'll read about — including the trend toward slightly greater average weight loss with tirzepatide in studies. But "greater on average" is not the same as "better for you," and I want to be honest about that from the start. The right medication is the one you tolerate, can access, can afford, and can stay on long enough to build lasting habits.

Here's a high-level comparison before we go deeper:

Think of this table as the map, not the destination. The sections below explain what's behind each row so you can have a genuinely informed conversation with your provider.

How each medication works

The reason these drugs feel so different from old-school diet pills is that they don't rely on willpower or stimulants. They work with your body's own hunger and fullness signaling — the hormones your gut releases when you eat.

Semaglutide: one pathway, well understood

Semaglutide mimics a natural hormone called GLP-1 (glucagon-like peptide-1) that your intestines release after meals. By activating the GLP-1 receptor, it does several things at once: it slows how quickly your stomach empties, signals fullness to the brain, and helps regulate blood sugar and insulin. The practical result for many people is less hunger, smaller portions, and much quieter "food noise" — that constant background chatter about the next snack.

Semaglutide is the more established of the two, with a longer real-world track record and both injectable and oral formulations. That longer history is genuinely reassuring for a lot of patients, and it's one reason we still start many people on it.

Tirzepatide: two hormones, one weekly shot

Tirzepatide is what's called a dual agonist — it activates both the GLP-1 receptor and a second one called GIP (glucose-dependent insulinotropic polypeptide). GIP is another gut hormone involved in how your body handles blood sugar and fat, and the working theory is that hitting two pathways at once produces a stronger combined effect on appetite and metabolism than GLP-1 alone.

That dual mechanism is the leading explanation for why tirzepatide has tended to outperform semaglutide on weight in studies. It's a newer molecule, so its long-term record is shorter, but the data so far have been striking.

What the weight-loss research actually shows

This is where marketing tends to get ahead of the science, so let me lay out the numbers carefully — and remind you that trial averages describe groups of people, not any one individual.

Large clinical trials studied each drug at its highest approved weight-management dose, on top of lifestyle counseling. Broadly speaking, semaglutide produced an average body-weight reduction in the mid-teens percentage range, while tirzepatide produced averages closer to 20% or above at its top dose. A head-to-head trial comparing the two for weight management found greater average weight loss with tirzepatide than with semaglutide.

A few honest caveats. First, these were carefully run studies with regular support and structured dose escalation — which is a big part of why we insist on real supervision rather than a mail-order prescription. Second, "up to 20%" is a ceiling seen at the highest tolerated dose in people who stayed on treatment; your result depends on your starting point, your dose, your consistency, and your biology. And third, we still don't have decades of data on either drug, so ongoing monitoring matters.

Side effects and safety: an honest look

No effective medication is free of trade-offs, and part of my job is making sure you understand them before you ever pick up a pen injector.

The common stuff: gastrointestinal effects

For both semaglutide and tirzepatide, the most frequent side effects are gastrointestinal — nausea, constipation, diarrhea, indigestion, and reflux. These are usually most noticeable in the first weeks and around each dose increase, and they tend to settle as your body adjusts. The single best way to minimize them is to titrate slowly, which means starting at a low dose and stepping up gradually rather than rushing to the highest strength.

Practical measures help a lot: smaller portions, eating slowly, easing off very fatty or fried foods, staying hydrated (which matters even more in our Florida heat), and not skipping the vegetables and fiber that keep things moving. When side effects are stubborn, we can hold a dose longer or step back — there's no prize for climbing the ladder faster than your body wants to.

The rarer but more serious risks

Both medications carry a boxed warning related to a risk of thyroid C-cell tumors observed in animal studies, and both list potential risks including pancreatitis, gallbladder problems, kidney strain from dehydration, and low blood sugar (especially when combined with insulin or certain diabetes medications). These serious events are uncommon, but they're the reason we take a thorough history and monitor you rather than simply handing over a prescription. We counsel every patient on the warning signs — severe or persistent abdominal pain, for example — that mean call us right away.

Who generally should not take these medications

Neither drug is appropriate for everyone. They're generally avoided in people with a personal or family history of medullary thyroid carcinoma or the syndrome MEN2, and they are not used during pregnancy or while trying to become pregnant. Extra caution applies with a history of pancreatitis, certain gallbladder or gastrointestinal conditions, and some other situations that we screen for at your consultation. This screening is not a formality — it's the whole point of doing this under medical supervision.

Cost, coverage, and the compounding question

For many patients on the Treasure Coast, cost is the deciding factor, so let's be plain about it.

Brand-name GLP-1 medications carry high list prices, often in the four-figures-per-month range before any insurance or manufacturer savings programs. Coverage is genuinely unpredictable: some plans cover these drugs for type 2 diabetes but not for weight loss, some require prior authorization or documented attempts at other approaches, and some don't cover them at all. Manufacturer savings cards and self-pay options can change the math significantly, and availability has fluctuated over time.

You may also have seen much cheaper "compounded" semaglutide and tirzepatide advertised online. Compounded versions are not the same as FDA-approved products and are not reviewed by the FDA for safety, effectiveness, or quality in the same way, so they carry different considerations that deserve a careful, individual conversation. We'll talk you through the current landscape honestly rather than steer you toward whatever is trendiest.

At Delphi we keep our program fees transparent, and you can review them anytime on our pricing & memberships page. What a given medication costs you, though, depends on your coverage — so we confirm that together before you commit to anything.

How we choose between them at Delphi

This is the question I love, because it's where medicine stops being a spec sheet and starts being about you. Our medical weight loss program treats weight as the metabolic, physiological story it is, and the choice between semaglutide and tirzepatide comes down to a handful of real-world factors.

• Your health history. Past pancreatitis, thyroid concerns, gallbladder issues, other medications, and your blood-sugar picture all shape what's safe and sensible for you.
• Your goals and starting point. How much weight you're aiming to lose, and how quickly it's medically reasonable to do so, informs which tool fits.
• Tolerance. If you've had a rough time with one medication's side effects, that's meaningful data — sometimes the "less powerful on paper" option is the one you can actually live with.
• Access and cost. The best drug in the world doesn't help if you can't get it or afford it, so coverage and supply are part of the clinical decision, not an afterthought.
• Response over time. We start low, titrate carefully, track body composition rather than just the scale, and adjust — including switching medications when the first choice isn't delivering.

Because so much of a program is conversation and dose management, a good portion of it can happen by telehealth across Florida, with body composition testing and hands-on steps done at our Port St. Lucie office or on a mobile visit in Fort Pierce, Vero Beach, Stuart, or Jensen Beach. That flexibility matters when you're busy or simply don't feel like driving.

Getting the most from either medication

Here's the truth that doesn't fit on a billboard: the medication opens a door, but what you do while it's open determines whether the results last.

Protect your muscle

Rapid weight loss can cost you lean muscle along with fat, and muscle is exactly what keeps your metabolism strong. We track body composition — not just pounds — and build in adequate protein and resistance activity so the weight you lose is the weight you want to lose. For some patients, addressing underlying hormonal shifts through hormone optimization is part of that bigger metabolic picture, particularly around perimenopause or midlife changes.

Build habits for maintenance

GLP-1 medications treat appetite and metabolism while you take them, which is why stopping abruptly without a plan often leads to regaining a significant share of the weight. We use your months on medication to establish nutrition patterns, movement you enjoy in our year-round Florida climate, and a maintenance strategy — which for some people means a lower long-term dose rather than stopping cold.

Stay supervised

Regular check-ins let us catch side effects early, adjust doses intelligently, monitor relevant labs, and keep you moving toward your goal instead of stalling on a plateau. This is the difference between a prescription and a program.

Education, not medical advice — and a warm invitation

Everything above is meant to inform you, not to diagnose you or replace a personal evaluation. Semaglutide and tirzepatide are powerful, prescription-only medications with real benefits and real risks, and whether either is right for you depends on details only a proper visit can uncover. Please don't start, stop, or source these medications based on a blog post — including this one.

If you're weighing your options here on the Treasure Coast, I'd genuinely love to help you think it through. At Delphi Health & Wellness, you get one clinician who knows your story, honest guidance about whether a GLP-1 fits you, and support at every step — in our Port St. Lucie office, at home, or by secure telehealth across Florida. When you're ready, book a visit and let's build a plan around your body, not the latest headline.